Department of Stomatology and Oral Pathology, School of Dentistry, Federal University of Ceará, Fortaleza, Ceará, Brazil.
Laboratory of Human and Medical Genetics, Graduate Program in Genetics and Molecular Biology, Federal University of Pará, Brazil.
J Oral Pathol Med. 2019 Sep;48(8):745-753. doi: 10.1111/jop.12929. Epub 2019 Aug 5.
The present study aimed to investigate the presence or absence of Streptococcus mutans in oral cavity and valvular samples associating with the histomorphologic alterations of calcified aortic stenosis.
Dental plaque and cardiac valve samples were collected from 10 patients with calcified aortic stenosis for molecular analysis of S mutans by real-time polymerase chain reaction (PCR). Healthy valve tissue was also collected from five young cadavers and analyzed for S mutans. Moreover, fragments of all valvar specimens were submitted for histomorphological analysis and immunohistochemistry (anti-S mutans and anti-CD61).
Streptococcus mutans was present in 100% of the oral cavity samples from the patients with calcified aortic stenosis in the molecular analysis. The analysis by real-time PCR showed that S mutans presented the same proportion in healthy valves and those with calcified aortic stenosis (80%; P = 1.000). Conversely, the immunoexpression of S mutans was 37.40 (IC95% = 1.49-937.00) times superior in samples of patients with cardiac disease (P = .007). The immunoexpression analysis showed that CD61 was present in seven (70%) calcified aortic stenosis samples, all of which were also immunopositive for S mutans.
Streptococcus mutans was found in the oral cavity, healthy valve tissue, and calcified aortic stenosis samples. However, the microorganism was visualized by immunohistochemistry only in the calcified aortic stenosis samples, which may suggest viability and an increased bacterial density in this condition. The association of the presence of S mutans and positive CD61 immunoexpression suggests a probable relationship with calcified aortic stenosis.
本研究旨在调查变形链球菌在口腔和瓣膜样本中是否存在,同时关联钙化性主动脉瓣狭窄的组织形态学改变。
对 10 例钙化性主动脉瓣狭窄患者的牙菌斑和心瓣膜样本进行分子分析,采用实时聚合酶链反应(PCR)检测 S 突变链球菌。还从 5 例年轻尸体的健康瓣膜组织中收集 S 突变链球菌进行分析。此外,所有瓣膜标本的片段均进行组织形态学分析和免疫组织化学分析(抗 S 突变链球菌和抗 CD61)。
在分子分析中,100%的钙化性主动脉瓣狭窄患者口腔样本中存在变形链球菌。实时 PCR 分析显示,健康瓣膜和钙化性主动脉瓣狭窄瓣膜中的 S 突变链球菌比例相同(80%;P=1.000)。相反,在心脏病患者的样本中,S 突变链球菌的免疫表达水平高 37.40 倍(95%CI95%=1.49-937.00)(P=0.007)。免疫表达分析显示,7 例(70%)钙化性主动脉瓣狭窄样本存在 CD61,且均为 S 突变链球菌免疫阳性。
在口腔、健康瓣膜组织和钙化性主动脉瓣狭窄样本中均发现变形链球菌。然而,只有在钙化性主动脉瓣狭窄样本中才通过免疫组织化学观察到该微生物,这可能表明在这种情况下该微生物具有活力且细菌密度增加。S 突变链球菌的存在与 CD61 免疫阳性的相关性提示其可能与钙化性主动脉瓣狭窄有关。